KR20180105129A - 이과학적 예방 및 치료를 위한 조성물 및 방법 - Google Patents

이과학적 예방 및 치료를 위한 조성물 및 방법 Download PDF

Info

Publication number
KR20180105129A
KR20180105129A KR1020187018607A KR20187018607A KR20180105129A KR 20180105129 A KR20180105129 A KR 20180105129A KR 1020187018607 A KR1020187018607 A KR 1020187018607A KR 20187018607 A KR20187018607 A KR 20187018607A KR 20180105129 A KR20180105129 A KR 20180105129A
Authority
KR
South Korea
Prior art keywords
patient
surfactant
ear
administering
surfactant composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020187018607A
Other languages
English (en)
Korean (ko)
Inventor
그레고리 제이. 플레서
캐서린 크리스프 터켈
앨런 제이. 마우톤
수잔나 에스. 찬드라세카
Original Assignee
노부스 테라퓨틱스, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 노부스 테라퓨틱스, 인크. filed Critical 노부스 테라퓨틱스, 인크.
Publication of KR20180105129A publication Critical patent/KR20180105129A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020187018607A 2015-11-30 2016-11-30 이과학적 예방 및 치료를 위한 조성물 및 방법 Withdrawn KR20180105129A (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201562260732P 2015-11-30 2015-11-30
US201562260734P 2015-11-30 2015-11-30
US201562260742P 2015-11-30 2015-11-30
US62/260,734 2015-11-30
US62/260,732 2015-11-30
US62/260,742 2015-11-30
PCT/US2016/064190 WO2017095905A1 (en) 2015-11-30 2016-11-30 Compositions and methods for otologic prophylaxis and treatment

Publications (1)

Publication Number Publication Date
KR20180105129A true KR20180105129A (ko) 2018-09-27

Family

ID=58778000

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020187018607A Withdrawn KR20180105129A (ko) 2015-11-30 2016-11-30 이과학적 예방 및 치료를 위한 조성물 및 방법

Country Status (8)

Country Link
US (1) US20170151173A1 (enExample)
EP (1) EP3383369A4 (enExample)
JP (1) JP2018535277A (enExample)
KR (1) KR20180105129A (enExample)
AU (1) AU2016365219A1 (enExample)
CA (1) CA3006563A1 (enExample)
MX (1) MX2018006575A (enExample)
WO (1) WO2017095905A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020142420A1 (en) * 2018-12-31 2020-07-09 Novus Therapeutics, Inc. Novel surfactant-lipid alloy drug substance, methods of making the same, and pharmaceutical compositions comprising the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029738A1 (en) * 1996-02-16 1997-08-21 The Administrators Of The Tulane Educational Fund Methods and compositions for treating eustachian tube dysfunction by inhalation
US5954682A (en) * 1996-09-25 1999-09-21 Advanced Medical Instruments Therapeutic applicator apparatus and method
CO4910145A1 (es) * 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
ATE271048T1 (de) * 1997-11-24 2004-07-15 Procter & Gamble 5-(2-imidazolinylamino)-benzimidazol derivate, deren herstellung und deren verwendung als .alpha.-adrenoceptor agonisten mit verbesserter metabolischer stabilität
US6676930B2 (en) * 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US20060207596A1 (en) * 2005-03-18 2006-09-21 Fairfield Clinical Trials, Llc Device and method for delivery of combination nasal medication
US8568790B2 (en) * 2006-05-31 2013-10-29 Medihoney Pty Ltd. Medicinal compositions containing honey
US8343464B2 (en) * 2010-04-30 2013-01-01 Burns Phillip E Composition and method for treating eustachian tube dysfunction
SG11201406208QA (en) * 2012-05-03 2014-11-27 Janssen Sciences Ireland Uc Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
EA201590124A1 (ru) * 2012-06-29 2015-06-30 Майкродоуз Терапьютикс, Инк. Композиции и способы лечения или предупреждения пневмовирусной инфекции и связанных заболеваний

Also Published As

Publication number Publication date
WO2017095905A1 (en) 2017-06-08
EP3383369A4 (en) 2019-06-12
US20170151173A1 (en) 2017-06-01
EP3383369A1 (en) 2018-10-10
AU2016365219A1 (en) 2018-07-05
MX2018006575A (es) 2018-12-06
JP2018535277A (ja) 2018-11-29
CA3006563A1 (en) 2017-06-08

Similar Documents

Publication Publication Date Title
Laube Devices for aerosol delivery to treat sinusitis
Madeiro et al. Transmission of oral pressure compromises oronasal CPAP efficacy in the treatment of OSA
Anderson et al. A randomized crossover efficacy trial of oral CPAP (Oracle) compared with nasal CPAP in the management of obstructive sleep apnea
Önerci et al. Diagnosis in Otorhinolaryngology: An Illustrated Guide
Bal et al. Management of Eustachian tube dysfunction: A review
Ciprandi et al. Intranasal flunisolide treatment in children with adenoidal hypertrophy
Vlckova et al. Effective treatment of mild-to-moderate nasal polyposis with fluticasone delivered by a novel device
Pulec Sinus tympani: retrofacial approach for the removal of cholesteatomas
Robin et al. Neonatal choanal atresia and stenosis
US20090277459A1 (en) Nasal Device Useful for Prevention of Snoring and Sleeping Apnea
Rosenfeld et al. Tympanostomy tube care and consequences
US20170151173A1 (en) Compositions and methods for otologic prophylaxis and treatment
Grewal et al. Tuberculous otitis media presenting as complications: report of 18 cases
RU2424821C1 (ru) Способ лечения экссудативного среднего отита у детей
Tumaisuri et al. Navigating Congenital Nasal Obstruction: A Contemporary Surgical Paradigm
Cho et al. Efficacy of Rhino-Protect ointment after endoscopic sinus surgery: a prospective, randomized, multicenter study
Na et al. Autoinflation After Tympanostomy Tube Extrusion in Otitis Media With Effusion: A Randomized Clinical Trial
Onder et al. Congenital midnasal stenosis: conservative management
RU2550966C1 (ru) Средство и способ лечения экссудативного среднего отита у детей
Hatch et al. Treatment options in the child with a chronic cough
Ilahi et al. The nose and associated structures: Part I
Syed et al. Acute management of croup in children
Fadhel et al. The role of n-acetylcysteine in the treatment of otitis media with effusion
Yehia Mostafa et al. Topical intranasal corticosteroids compared with oral steroids in the Treatment of Eustachian tube dysfunction in children
Moffa et al. Impact of intranasal nebulized ectoine on morbidity and short-term quality of life after pediatric adenoidectomy

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20180629

Patent event code: PA01051R01D

Comment text: International Patent Application

N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20180904

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid